MedPage Today on MSN12d
Apixaban Has Edge Over Other OACs for Older HIV Patients With AfibWarfarin was associated with more risk than apixaban (Eliquis; 55.38 vs 21.42 per 1,000 person-years, HR 2.60, 95% CI ...
Taho Pharmaceuticals’s apixaban-based oral dissolving strips were discovered to be a bioequivalent of Pfizer and Bristol-Myers Squibb’s (BMS) Eliquis in a Phase II trial. The randomised open ...
Clinical Trials Arena on MSN19d
Taho Pharma’s apixaban oral strips equivalent to Eliquis in pivotal trialTaho Pharmaceuticals’s apixaban-based oral dissolving strips were discovered to be a bioequivalent of Pfizer and Bristol-Myers Squibb’s (BMS) Eliquis in a Phase II trial. The randomised open-label ...
The mean follow-up duration was 20 months. In the NOAC group, apixaban (Eliquis; Bristol Myers Squibb/Pfizer) was used in four trials, rivaroxaban (Xarelto; Janssen/Bayer) in two trials, dabigatran ...
aspirin.” The analysis included nine trials, all of which compared apixaban (Eliquis, Bristol Myers Squibb/Pfizer), dabigatran (Pradaxa, Boehringer Ingelheim) or rivaroxaban (Xarelto ...
The study confirmed that TAH3311 is bioequivalent to U.S. and European reference Apixaban tablets (Eliquis®) under fasting conditions, with Cmax and AUC values falling within the regulatory ...
The study confirmed that TAH3311 is bioequivalent to U.S. and European reference Apixaban tablets (Eliquis®) under fasting conditions, with Cmax and AUC values falling within the regulatory acceptance ...
Welcome to Medicare Part D, where your prescription drugs come with co-pays and co-insurance. If you thought co-pays and ...
Among those assigned to a DOAC, 53.8% used apixaban (Eliquis, Bristol Myers Squibb/Pfizer), 20.9% used dabigatran (Pradaxa, Boehringer Ingelheim), 18.4% used edoxaban (Savaysa, Daiichi Sankyo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback